Navigation Links
Cardinal Health Board Of Directors Raises Quarterly Dividend
Date:10/30/2012

DUBLIN, Ohio, Oct. 30, 2012 /PRNewswire/ -- Cardinal Health today announced that its board of directors has approved a 16 percent increase in the company's quarterly dividend to $0.275 per share, or $1.10 per share on an annualized basis. 

The quarterly dividend is payable on Jan. 15, 2013, to shareholders of record at the close of business on Jan. 2, 2013.

The dividend increase is in addition to a 10.5 percent increase realized in July 2012. This action represents the company's continued commitment to total shareholder return through strategic investments for future growth, dividend payouts and share repurchase. 

About Cardinal Health
Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is a $108 billion health care services company that improves the cost-effectiveness of health care. As the business behind health care, Cardinal Health helps pharmacies, hospitals, ambulatory surgery centers and physician offices focus on patient care while  reducing costs, enhancing efficiency and improving quality. Cardinal Health is an essential link in the health care supply chain, providing pharmaceuticals and medical products to more than 60,000 locations each day. The company is also a leading manufacturer of medical and surgical products, including gloves, surgical apparel and fluid management products. In addition, the company supports the growing diagnostic industry by supplying medical products to clinical laboratories and operating the nation's largest network of radiopharmacies that dispense products to aid in the early diagnosis and treatment of disease. Ranked #21 on the Fortune 500, Cardinal Health employs more than 30,000 people worldwide. More information about the company may be found at cardinalhealth.com and @CardinalHealth on Twitter.

This news release contains forward-looking statements addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments. These statements may be identified by words such as "expect," "anticipate," "intend," "plan," "believe," "will," "should," "could," "would," "project," "continue," "likely," and similar expressions, and include statements reflecting future results or guidance, statements of outlook and expense accruals. These matters are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. These risks and uncertainties include competitive pressures in Cardinal Health's various lines of business; the loss of one or more key customer or supplier relationships or changes to the terms of those relationships, including our relationships with CVS Caremark Corporation and Walgreen Co.; the timing of generic and branded pharmaceutical introductions and the frequency or rate of pharmaceutical price appreciation or deflation; uncertainties due to government health care reform including federal health care reform legislation; changes in the distribution patterns or reimbursement rates for health care products and services; the effects of any investigation or action by any regulatory authority; changes in the cost of commodities such as oil-based resins, cotton, latex and diesel fuel; uncertainties concerning Cardinal Health's ability to achieve the expected benefits of its Medical segment's business transformation project; and with respect to future dividends, the decision by Cardinal Health's board of directors to declare such dividends, which decision will depend on Cardinal Health's surplus, earnings, cash flows, financial condition and prospects at the time any such action is considered. Cardinal Health is subject to additional risks and uncertainties described in Cardinal Health's Form 10-K, Form 10-Q and Form 8-K reports and exhibits to those reports. This news release reflects management's views as of October 30, 2012. Except to the extent required by applicable law, Cardinal Health undertakes no obligation to update or revise any forward-looking statement.


'/>"/>
SOURCE Cardinal Health
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. QIAGEN and Cardinal Health Collaborate to Offer Molecular Diagnostic Products to Smaller and Mid-sized U.S. Hospitals
2. Cardinal Health Reports Third-Quarter Results
3. Cardinal Health Brings Resolution to Litigation with DEA Settlement
4. Cardinal Health Specialty Solutions Launches PathWare™ Decision Support Transaction Solutions
5. Cardinal Health, Detroit Medical Center, Henry Ford Health System Announce Unique Collaboration To Promote Urban Renewal
6. Medical Oncology Association of Southern California Purchasing Network (MPN) Names Cardinal Health Specialty Solutions as its Primary Healthcare Solutions Partner
7. Cardinal Health Honored With Best Employers for Healthy Lifestyles Award by National Business Group on Health
8. Cardinal Health To Release Fourth-Quarter And Full-Year Results For Fiscal Year 2012 On Aug. 2
9. Cardinal Health Celebrates Community Pharmacists Commitment to Patient Care at Annual Trade Show for Independent Pharmacies
10. Cardinal Health Highlights Independent Pharmacy Best Practices At Retail Business Conference 2012
11. Cardinal Health Supports Future Pharmacists With Nearly $1 Million In Scholarships
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... it has concluded agreements with the U.S. Department of ... (SEC) to resolve the previously disclosed U.S. Foreign Corrupt ... as in relation to the former deferred prosecution agreement ... with DOJ and SEC, respectively, on March 26, 2012.  ...
(Date:1/12/2017)... 2017  BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical ... findings at this week,s Orlando Dermatology Aesthetic & Clinical (ODAC) ... acnes -induced inflammation. The data will be shared ... Acne Pathogenesis," at ODAC, which is being held Jan. 13-16 ... ...
(Date:1/12/2017)... -- This new report from VPGMarketResearch contains 897 pages, ... German hospital microbiology testing market, including:  ... practice, as well as key economic, regulatory, demographic, social ... next ten years.  ... of major infectious diseases and microorganisms.  ...
Breaking Medicine Technology:
(Date:1/13/2017)... ... January 13, 2017 , ... ... world’s first and most comprehensive franchise ranking. Recognized by entrepreneurs and franchisors as ... for its exceptional performance in areas including financial strength and stability, growth rate, ...
(Date:1/13/2017)... ... January 13, 2017 , ... "Devotions from the Heart" ... crafts, and antique hunting. She and her husband, Gene, reside in Missoula, Montana, with ... wait and learn to lean upon His strength., So keep trusting in the Master ...
(Date:1/13/2017)... Viejo, California (PRWEB) , ... January 13, 2017 , ... ... back into any video project," said Christina Austin - CEO of Pixel Film Studios. ... drop transition presets. Each preset contains a unique shadow fade that masks the first ...
(Date:1/13/2017)... ... January 13, 2017 , ... Dr. Les Latner, ... of a fundraising campaign for the American Academy of Cosmetic Dentistry Charitable Foundation ... assist in rebuilding the smiles and lives of adults who have suffered dental ...
(Date:1/13/2017)... ... January 13, 2017 , ... Sharon Kleyne, America’s leading water researcher, advocate ... Water, Global Climate Change and Your Health on Voice America, celebrated on January 9th ... yesterday,” said Sharon Kleyne to her listening audience, “yet here it is the beginning ...
Breaking Medicine News(10 mins):